Oppenheimer Downgrades Capricor Therapeutics (CAPR) to Perform

July 30, 2026 7:54 AM

Oppenheimer analyst Leland Gershall downgraded Capricor Therapeutics (NASDAQ: CAPR) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found